🇺🇸 FDA
Patent

US 7431931

Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions

granted A61KA61K2039/5254A61K2039/542

Quick answer

US patent 7431931 (Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/5254, A61K2039/542, A61K2039/545, A61K2039/55